#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Langerhans cell sarcoma Porphyria non-acute Small for dates baby Nephrotic syndrome Immune-mediated myasthenia gravis Myelodysplastic syndrome with excess blasts Ataxia telangiectasia Oesophageal adenocarcinoma stage II Epileptic encephalopathy General anaesthesia Adenomatous polyposis coli Hypocalcaemia Epilepsy with myoclonic-atonic seizures Mantle cell lymphoma stage III Biotinidase deficiency More trials…

    Learn about Rare Diseases

    Gastrointestinal stromal tumour Familial haemophagocytic lymphohistiocytosis – Treatment Gaucher’s disease type III – Diagnostics Breast angiosarcoma – Basic Information Angiosarcoma non-metastatic – Treatment Synovial sarcoma metastatic – Diagnostics Glomerulonephritis membranoproliferative – Life with Disease Mastocytosis Pituitary-dependent Cushing’s syndrome – Trials in Disease Systemic mastocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tetracosactide Trimetazidine Dihydrochloride Esflurbiprofen Clodronate Disodium Msv-Allo Betaine Citrate Indometacin Cevostamab Immunoglobulin M Sasanlimab Bifikafusp Alfa Gebasaxturev ALN-4324 DAPIGLUTIDE SAR445399 Ampreloxetine Remestemcel Allo-647 Nifedipine L-Ascorbic Acid More therapies…

    Learn about Your Condition

    Desmoid tumour Periarthritis Muscle spasticity Deafness neurosensory Prodromal Alzheimer's disease Carpal tunnel syndrome Cleft lip and palate Intracranial aneurysm Abdominal infection Spermatocele Post procedural swelling Erdheim-Chester disease Acute respiratory failure Glomerulonephritis CADASIL More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Vitamin D3 and Glycerol for Reducing Fatigue in Colorectal Cancer Patients with Low Vitamin D Levels After Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Colecalciferol
    • Glycerol
    Germany

  • Live Attenuated Influenza Vaccine (LAIV) and Immune Response in the Nasopharynx of Young Children with Influenza

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • INFLUENZA VIRUS B/AUSTRIA/1359417/2021 – LIKE STRAIN (B/AUSTRIA/1359417/2021, MEDI 355292)
    The Netherlands

  • Study on Dexamethasone Film for Patients with Acute Allergic Reactions

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone
    Sweden

  • Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

    Not recruiting

    3 1
    Bulgaria Czechia Germany Hungary Poland Romania +2

  • Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

    Not recruiting

    3 1
    Investigated Drugs:
    • Itepekimab
    Austria Belgium Czechia Denmark Finland France +9

  • Study on the Effectiveness and Safety of CR9114 for Preventing Influenza in Healthy Adults

    Not recruiting

    2 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • WILD-TYPE A INFLUENZA VIRUS A/BELGIUM/4217/2015 (H3N2)
    Belgium
Previous Page
1 … 1,658 1,659 1,660 1,661 1,662 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!